Warren Buffett's Berkshire Hathaway Sells $116M Shares Of Dialysis Giant DaVita, Cuts Stake By 2%
Warren Buffett's investment firm, Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B), has offloaded a 2% stake in dialysis service provider, DaVita Inc. (NYSE: DVA). The transaction, executed between February 14 and 19,
Warren Buffett (Trades, Portfolio)'s Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) just offloaded another 750,000 shares of ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
As DaVita marks a major milestone, its top executive reveals where the Dever-beased business and its 3,000 downtown employees ...
Dialysis firm DaVita projected annual profit below estimates on Thursday due to rising patient care costs, sending its shares down 11% in after-hours trading.
TD Cowen analyst Gary Taylor raised the firm’s price target on DaVita (DVA) to $165 from $150 and keeps a Hold rating on the shares. The firm ...
Chevy Chase Trust Holdings LLC trimmed its position in DaVita Inc. (NYSE:DVA – Free Report) by 4.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange ...
Warren Buffett's Berkshire Hathaway said it sold 750,000 shares of DaVita between February 14 and 19, reducing its stake in ...
Analysts fell to the sidelines weighing in on DaVita (DVA – Research Report) and Charles River Labs (CRL – Research Report) with neutral ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback